Pomalyst
Brand for: Pomalidomide
My Prescription
Payment
Select pharmacy
$1,174.68
$30.00 due at pharmacy
$1,174.68 - $30.00 = $1,144.68
$1,144.68 remaining balance
You will be given your coupon after you complete your purchase with PayPal.
WalgreensPowered by$1,174.68
Print or send this coupon to your phone
WalgreensPowered byAbout Pomalyst
Drug Details
Pomalidomide, marketed as Pomalyst, is an oral medication used to treat specific types of cancer, including multiple myeloma and Kaposi sarcoma. It is particularly prescribed for patients with multiple myeloma who have previously undergone at least two treatments that included lenalidomide (Revlimid) and a proteasome inhibitor such as bortezomib (Velcade). Pomalyst is taken once daily for 21 days in a 28-day cycle. The drug works by enhancing the immune system's ability to target and destroy cancer cells. It also disrupts the growth of cancer cells by interfering with certain proteins and inhibits the formation of new blood vessels that supply these cells, thereby slowing the progression of the disease. Due to its potential for serious side effects, including blood clots and birth defects, Pomalyst is distributed under a controlled program known as the Risk Evaluation and Mitigation Strategy (REMS).
Price history for Pomalyst (brand) & Pomalidomide (generic)
21 Capsules, 1MG
Average retail price for Pomalyst
Average retail price for Pomalidomide
Average SaveHealth price for Pomalidomide
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
Over the last 12 months, the average discount price of Pomalyst is $5069.60 using the SaveHealth savings card. That's an average savings of 83.47% on Pomalyst with our discount card.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Pomalyst (Pomalidomide) dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 1MG | 21 Capsules | $1,174.68 | $55.94 |
| 2MG | 21 Capsules | $1,176.15 | $56.01 |
| 3MG | 21 Capsules | $1,536.30 | $73.16 |
| 4MG | 21 Capsules | $1,530.84 | $72.90 |
Pomalyst FAQs
Yes, Pomalyst (pomalidomide) is considered a type of chemotherapy drug. It is an immunomodulatory agent used primarily in the treatment of multiple myeloma.
The effectiveness of Pomalyst (pomalidomide) versus Revlimid (lenalidomide) depends on the specific medical condition being treated and the individual patient's response to the medication. Both drugs are used in the treatment of multiple myeloma, but they may be prescribed at different stages of the disease or in different combinations with other treatments. A healthcare provider would consider various factors, including the patient's medical history, previous treatments, and overall health, to determine which medication is more appropriate. It is important for patients to discuss with their healthcare provider to understand which option is better suited for their specific situation.
The cost of Pomalyst can vary significantly based on factors such as the pharmacy, location, insurance coverage, and dosage prescribed. Without insurance, the price can be quite high, often several thousand dollars for a month's supply. It is advisable for individuals to check with their specific pharmacy and insurance provider for the most accurate and up-to-date pricing information. Additionally, there may be patient assistance programs available to help offset the cost.
The choice between pomalidomide and lenalidomide depends on the specific medical condition being treated, the stage of the disease, and the patient's individual response to treatment. Both drugs are used primarily in the treatment of multiple myeloma, but they may be used at different stages of the disease or in different combinations with other therapies. A healthcare provider would consider factors such as previous treatments, side effect profiles, and overall health of the patient when determining which medication is more appropriate. It is essential for patients to discuss with their healthcare provider to determine the best treatment option for their specific situation.
Pomalyst is typically covered under Medicare Part D, not Part B. Medicare Part D covers prescription drugs that are usually self-administered, while Part B generally covers drugs that are administered in a clinical setting. Beneficiaries should check with their specific Medicare Part D plan for coverage details and any associated costs.